![Richard Gaynor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Gaynor
Direktor/Vorstandsmitglied bei
ALKERMES PLC
Vermögen: 4 Mio $ am 31.08.2026
Profil
Richard Brian Gaynor is currently Director at Alkermes, Inc. since 2019, Director at The Damon Runyon Cancer Research Foundation, Independent Director at Alkermes Plc since 2019, and Independent Director at Zai Lab Ltd. since 2021.
Former positions include Independent Director at Infinity Pharmaceuticals, Inc. from 2020 to 2024, President-Research & Development at BioNTech US, Inc. from 2016 to 2020, Vice President-Clinical Development at Eli Lilly & Co. from 2002 to 2015, Senior VP-Clinical Development & Medical Affairs at Lilly Oncology, Director-Simmons Cancer Center at The University of Texas Southwestern Medical Center from 1998 to 2002, and Director & Chief-Hematology at Harold C Simmons Comprehensive Cancer Center.
Education includes undergraduate studies at Texas Tech University and a doctorate from The University of Texas Southwestern Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZAI LAB LTD. 0.07% | 01.07.2026 | 807’370 ( 0.07% ) | 2 Mio $ | 31.08.2026 |
| 21.05.2026 | 35’751 ( 0.02% ) | 2 Mio $ | 31.08.2026 |
Aktive Positionen von Richard Gaynor
| Unternehmen | Position | Beginn |
|---|---|---|
| ALKERMES PLC | Direktor/Vorstandsmitglied | 12.09.2019 |
| ZAI LAB LIMITED | Direktor/Vorstandsmitglied | 19.11.2021 |
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Direktor/Vorstandsmitglied | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Direktor/Vorstandsmitglied | 01.09.2019 |
Ehemalige bekannte Positionen von Richard Gaynor
| Unternehmen | Position | Ende |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.03.2024 |
| NEON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2020 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.10.2016 |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.08.2002 |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Ausbildung von Richard Gaynor
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Texas Tech University
 Texas Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Commercial Services |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Harold C Simmons Comprehensive Cancer Center |
